According to the American Diabetes Association Standards of Care, GLP-1 receptor agonists produce weight loss through multiple mechanisms including central appetite regulation and delayed gastric emptying, beyond gastrointestinal side effects alone
Janicka A, Szymanska-Pasternak J, Bober J
Who should not use HCG injection
7 These pathways are shown in FIGURE 1
This review aims to explore the effects of GLP-1R signaling on various immune cells and evaluate the therapeutic potential of GLP-1RAs in autoimmune and autoinflammatory diseases, including psoriasis, inflammatory bowel diseases, rheumatoid arthritis, asthma, multiple sclerosis, Sjgrens syndrome, and systemic lupus erythematosus